These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
180 related articles for article (PubMed ID: 39375795)
21. Immunosuppressive tumor-associated macrophages expressing interlukin-10 conferred poor prognosis and therapeutic vulnerability in patients with muscle-invasive bladder cancer. Xu Y; Zeng H; Jin K; Liu Z; Zhu Y; Xu L; Wang Z; Chang Y; Xu J J Immunother Cancer; 2022 Mar; 10(3):. PubMed ID: 35338085 [TBL] [Abstract][Full Text] [Related]
22. The contribution of tumor-associated macrophages in glioma neo-angiogenesis and implications for anti-angiogenic strategies. Zhu C; Kros JM; Cheng C; Mustafa D Neuro Oncol; 2017 Oct; 19(11):1435-1446. PubMed ID: 28575312 [TBL] [Abstract][Full Text] [Related]
23. GPR65 sensing tumor-derived lactate induces HMGB1 release from TAM via the cAMP/PKA/CREB pathway to promote glioma progression. Yan C; Yang Z; Chen P; Yeh Y; Sun C; Xie T; Huang W; Zhang X J Exp Clin Cancer Res; 2024 Apr; 43(1):105. PubMed ID: 38576043 [TBL] [Abstract][Full Text] [Related]
24. Glioma: bridging the tumor microenvironment, patient immune profiles and novel personalized immunotherapy. Mishchenko TA; Turubanova VD; Gorshkova EN; Krysko O; Vedunova MV; Krysko DV Front Immunol; 2023; 14():1299064. PubMed ID: 38274827 [TBL] [Abstract][Full Text] [Related]
25. Single-Cell RNA Sequencing Pro-angiogenic Macrophage Profiles Reveal Novel Prognostic Biomarkers and Therapeutic Targets for Osteosarcoma. Yi C; Li Z; Zhao Q; Gong D; Zhao S; Chen Z; Cheng C; Bian E; Tian D Biochem Genet; 2024 Apr; 62(2):1325-1346. PubMed ID: 37603193 [TBL] [Abstract][Full Text] [Related]
26. MELK is a prognostic biomarker and correlated with immune infiltration in glioma. Yang H; Zhou H; Wang G; Tian L; Li H; Zhang Y; Xue X Front Neurol; 2022; 13():977180. PubMed ID: 36353126 [TBL] [Abstract][Full Text] [Related]
27. Characterization of microglia/macrophages in gliomas developed in S-100β-v-erbB transgenic rats. Sasaki A; Yokoo H; Tanaka Y; Homma T; Nakazato Y; Ohgaki H Neuropathology; 2013 Oct; 33(5):505-14. PubMed ID: 23331472 [TBL] [Abstract][Full Text] [Related]
28. Tumor-associated macrophages in glioma: friend or foe? Kennedy BC; Showers CR; Anderson DE; Anderson L; Canoll P; Bruce JN; Anderson RC J Oncol; 2013; 2013():486912. PubMed ID: 23737783 [TBL] [Abstract][Full Text] [Related]
30. Hypoxia-induced polypoid giant cancer cells in glioma promote the transformation of tumor-associated macrophages to a tumor-supportive phenotype. Liu Y; Shi Y; Wu M; Liu J; Wu H; Xu C; Chen L CNS Neurosci Ther; 2022 Sep; 28(9):1326-1338. PubMed ID: 35762580 [TBL] [Abstract][Full Text] [Related]
31. Blocking LTB Yan J; Zhu J; Li X; Yang R; Xiao W; Huang C; Zheng C Phytomedicine; 2023 Oct; 119():154968. PubMed ID: 37531900 [TBL] [Abstract][Full Text] [Related]
32. The diversity and dynamics of tumor-associated macrophages in recurrent glioblastoma. Zhang L; Jiang Y; Zhang G; Wei S Front Immunol; 2023; 14():1238233. PubMed ID: 37731483 [TBL] [Abstract][Full Text] [Related]
33. Plasminogen Activator Urokinase Receptor Implies Immunosuppressive Features and Acts as an Unfavorable Prognostic Biomarker in Glioma. Zeng F; Li G; Liu X; Zhang K; Huang H; Jiang T; Zhang Y Oncologist; 2021 Aug; 26(8):e1460-e1469. PubMed ID: 33687124 [TBL] [Abstract][Full Text] [Related]
34. Identification of TREM2-positive tumor-associated macrophages in esophageal squamous cell carcinoma: implication for poor prognosis and immunotherapy modulation. Li H; Miao Y; Zhong L; Feng S; Xu Y; Tang L; Wu C; Zhang X; Gu L; Diao H; Wang H; Wen Z; Yang M Front Immunol; 2023; 14():1162032. PubMed ID: 37187751 [TBL] [Abstract][Full Text] [Related]
35. The prognostic value of tumor-associated macrophages in glioma patients. Shen Y; Zheng D; Hu D; Ma B; Cai C; Chen W; Zeng J; Luo J; Xiao D; Zhao Y; Wu Z; Jing G; Xie Y Medicine (Baltimore); 2023 Sep; 102(38):e35298. PubMed ID: 37747032 [TBL] [Abstract][Full Text] [Related]
36. Tumor Associated Macrophages, as the Dominant Immune Cells, Are an Indispensable Target for Immunologically Cold Tumor-Glioma Therapy? Tong N; He Z; Ma Y; Wang Z; Huang Z; Cao H; Xu L; Zou Y; Wang W; Yi C; Yin Z; Wang Q Front Cell Dev Biol; 2021; 9():706286. PubMed ID: 34368156 [TBL] [Abstract][Full Text] [Related]
37. Tumor-associated macrophages and PD-L1 in prostate cancer: a possible key to unlocking immunotherapy efficacy. Wang J; Wu W; Yuan T; Wang L; Zang L; Liu Q; Wang L; Huo X; Huo B; Tang Y; Wang H; Zhao Z Aging (Albany NY); 2024 Jan; 16(1):445-465. PubMed ID: 38189834 [TBL] [Abstract][Full Text] [Related]
38. M2 macrophage marker CHI3L2 could serve as a potential prognostic and immunological biomarker in glioma by integrated single-cell and bulk RNA-Seq analysis. Qian W; Wang Q; Zhang C; Zhu J; Zhang Q; Luo C J Gene Med; 2023 Sep; 25(9):e3523. PubMed ID: 37147894 [TBL] [Abstract][Full Text] [Related]
39. Orphan nuclear receptor TLX promotes immunosuppression via its transcriptional activation of PD-L1 in glioma. Zhou J; Pei X; Yang Y; Wang Z; Gao W; Ye R; Zhang X; Liu J; Liu Z; Yang X; Tao J; Gu C; Hu W; Chan FL; Li X; Mao J; Wu D J Immunother Cancer; 2021 Apr; 9(4):. PubMed ID: 33858847 [TBL] [Abstract][Full Text] [Related]
40. BCL2A1 is associated with tumor-associated macrophages and unfavorable prognosis in human gliomas. Gao L; Ye Z; Peng S; Lei P; Song P; Li Z; Zhou L; Hua Q; Cheng L; Wei H; Liu J; Cai Q Aging (Albany NY); 2023 Oct; 15(20):11611-11638. PubMed ID: 37889551 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]